Mahesh K B Parmar Selected Research

Mahesh K B Parmar Research Topics

Disease

47	Prostatic Neoplasms (Prostate Cancer) 05/2024 - 09/2003
12	Neoplasms (Cancer) 02/2023 - 05/2003
11	Neoplasm Metastasis (Metastasis) 05/2024 - 09/2003
8	Ovarian Neoplasms (Ovarian Cancer) 01/2023 - 07/2003
4	Disease Progression 01/2022 - 06/2007
4	Renal Cell Carcinoma (Grawitz Tumor) 01/2022 - 02/2010
4	Head and Neck Neoplasms (Head and Neck Cancer) 01/2021 - 05/2010
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 03/2015
3	Hypertension (High Blood Pressure) 01/2022 - 12/2011
3	COVID-19 01/2022 - 04/2021
3	Adenocarcinoma 01/2022 - 01/2016
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2020 - 05/2010
3	Colorectal Neoplasms (Colorectal Cancer) 10/2012 - 06/2008
2	Opiate Overdose 01/2017 - 02/2015
2	Urinary Bladder Neoplasms (Bladder Cancer) 06/2011 - 10/2009
1	Melanoma (Melanoma, Malignant) 01/2023
1	Kidney Neoplasms (Kidney Cancer) 01/2023
1	Sudden Death 01/2022
1	Septic Shock (Toxic Shock Syndrome) 01/2022
1	Carcinoma (Carcinomatosis) 01/2021
1	Urinary Incontinence 10/2020
1	Urethral Stricture 10/2020
1	Parkinson Disease (Parkinson's Disease) 01/2020
1	Squamous Cell Neoplasms (Squamous Cell Cancer) 01/2017
1	Nasopharyngeal Carcinoma 01/2017
1	Multiple Endocrine Neoplasia Type 2a (MEN 2) 03/2016
1	Hypothyroidism 03/2016
1	Neutropenia 03/2016
1	Sarcoidosis (Schaumann Disease) 08/2015
1	Fistula 08/2015
1	Heart Failure 08/2015
1	Respiratory Insufficiency (Respiratory Failure) 10/2013
1	Testicular Neoplasms (Testicular Cancer) 04/2012
1	Body Weight (Weight, Body) 12/2011
1	Pathologic Complete Response 10/2010

Drug/Important Bio-Agent (IBA)

24	Hormones (Hormone)IBA 02/2023 - 09/2003
20	AndrogensIBA 05/2024 - 06/2007
9	Prostate-Specific Antigen (Semenogelase)IBA 05/2024 - 12/2011
9	abirateroneIBA 02/2023 - 11/2014
8	Docetaxel (Taxotere)FDA Link 01/2023 - 02/2009
8	Abiraterone AcetateIBA 01/2023 - 01/2017
6	Prednisolone (Predate)FDA LinkGeneric 01/2023 - 01/2017
4	Biomarkers (Surrogate Marker)IBA 01/2023 - 06/2008
4	Diphosphonates (Bisphosphonates)IBA 02/2016 - 09/2003
3	enzalutamideIBA 01/2023 - 11/2014
3	Monoclonal AntibodiesIBA 01/2022 - 10/2012
3	Carboplatin (JM8)FDA LinkGeneric 01/2019 - 12/2011
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2019 - 12/2011
3	Bevacizumab (Avastin)FDA Link 01/2019 - 12/2011
3	Celecoxib (Celebrex)FDA Link 05/2017 - 02/2009
3	Zoledronic Acid (Zometa)FDA Link 05/2017 - 02/2009
3	Clodronic Acid (Clodronate)IBA 09/2009 - 09/2003
2	antiarrhythmic peptide (AAP)IBA 10/2022 - 01/2022
2	Prednisone (Sone)FDA LinkGeneric 10/2022 - 01/2022
2	bamlanivimabIBA 01/2022 - 11/2021
2	Sorafenib (BAY 43-9006)FDA Link 01/2022 - 12/2020
2	remdesivirIBA 01/2022 - 11/2021
2	DNA (Deoxyribonucleic Acid)IBA 11/2020 - 06/2008
2	Naloxone (Narcan)FDA LinkGeneric 01/2017 - 02/2015
2	Estradiol (Delestrogen)FDA LinkGeneric 01/2017 - 01/2016
2	PlatinumIBA 03/2016 - 10/2010
2	Cisplatin (Platino)FDA LinkGeneric 06/2011 - 05/2008
2	Vinblastine (Vinblastine Sulfate)FDA Link 06/2011 - 05/2008
2	Fluorouracil (Carac)FDA LinkGeneric 02/2010 - 06/2008
1	InterferonsIBA 02/2023
1	Androgen Receptors (Androgen Receptor)IBA 02/2023
1	pembrolizumabIBA 01/2023
1	Acetates (Acetic Acid Esters)FDA Link 01/2022
1	Alanine (L-Alanine)FDA Link 01/2022
1	AntigensIBA 01/2022
1	Antiviral Agents (Antivirals)IBA 04/2021
1	VaccinesIBA 04/2021
1	ParaffinIBA 11/2020
1	Formaldehyde (Formol)FDA Link 11/2020
1	Dihydrotachysterol (AT 10)IBA 10/2020
1	Narcotic Antagonists (Opioid Antagonists)IBA 01/2017
1	cediranib (AZD2171)IBA 03/2016
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 03/2016
1	Testosterone (Sustanon)FDA Link 01/2016
1	Tyrosine Kinase InhibitorsIBA 05/2015
1	ErbB Receptors (EGF Receptor)IBA 05/2015
1	Opiate AlkaloidsIBA 10/2013
1	Heroin (Diamorphine)IBA 10/2013
1	Methotrexate (Mexate)FDA LinkGeneric 06/2011
1	Interferon alpha-2 (Roferon-A)FDA Link 02/2010

Therapy/Procedure

40	Therapeutics 05/2024 - 09/2003
28	Radiotherapy 05/2024 - 05/2003
16	Drug Therapy (Chemotherapy) 01/2021 - 07/2003
4	Prostatectomy (Retropubic Prostatectomy) 05/2024 - 10/2020
2	Nephrectomy 01/2022 - 01/2021
2	Chemoradiotherapy 01/2021 - 01/2017
2	Adjuvant Radiotherapy 10/2020 - 10/2020
2	Neoadjuvant Therapy 12/2018 - 06/2011
2	Conformal Radiotherapy 04/2014 - 06/2007
2	Cystectomy 06/2011 - 05/2003
1	Immunotherapy 01/2023
1	Resuscitation 01/2017
1	Adjuvant Chemotherapy 03/2015
1	Orchiectomy (Orchidectomy) 04/2012
1	Treatment Delay 10/2010